Zhang Wenhong

Director of the Department of Internal Medicine at the Clinical Medical College of Fudan University, Director of the Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, and Head of the Shanghai Expert Group for COVID-19 Medical Treatment. Member of the WHO Tuberculosis Prevention and Control Guidelines Expert Group and Vice Chairman of the Infectious Diseases Branch of the Chinese Medical Association. Graduated from the Department of Medicine, Shanghai Medical University, and furthered his studies at Harvard Medical School's BI Medical Center and Queen Mary Hospital, University of Hong Kong. He has long been engaged in the investigation and treatment of unexplained fever and various difficult infectious diseases. He led and completed the national "15th Five-Year Plan" research project on drug-resistant infectious diseases. He is a Changjiang Scholar Dr. appointed by the Ministry of Education, a National Health Commission Outstanding Young and Middle-aged Expert, a National Advanced Individual in the Fight Against COVID-19, a National Outstanding Communist Party Member, and an expert enjoying special government allowances from the State Council. He has long been committed to the diagnosis and treatment of complex infectious diseases, focusing on research into new strategies for the functional cure of chronic hepatitis B, including fever of unknown origin and treatment of multidrug-resistant tuberculosis. The department he leads treats over 10,000 cases of complex and severe infectious diseases annually, with patient satisfaction consistently above 96%. He spearheaded the TB-TRUST all-oral short-course regimen, which reduced tuberculosis treatment costs by over 90% and achieved a cure rate of over 80% for multidrug-resistant tuberculosis; he also promoted the revision of the expert consensus on the diagnosis and treatment of fever of unknown origin (2025 edition). He has published over 300 papers as first author/corresponding author, including over 200 SCI papers, and has obtained 9 national patents. He has also edited or co-edited over 20 monographs. Since 2013, he has established the first national platform for precise diagnosis of infectious disease pathogens, and for the first time globally, he has verified the cross-species transmission of porcine pseudorabies virus from both etiological and immunological perspectives.